BioWorld Today: U.S. Patent Disclosure - AccelRx Pharmaceuticals, Inc.
September 28, 2012 - BioWorld Today
AcelRx Pharmaceuticals Inc., of Redwood City, Calif., received U.S. Patent No. 8,252,328 and No. 8,252,329, “Bioadhesive Drug Formulations for Oral Transmucosal Delivery.” Both cover the composition of sufentanil NanoTabs, a product line for pain.
